Report Content
Chapter 1 Methodology & Scope
1.1 Market definitions
1.2 Base estimates and working
1.3 Forecast calculations.
1.4 Region-wise COVID-19 impact analysis:
1.4.1 North America
1.4.2 Europe
1.4.3 APAC
1.4.4 MEA
1.4.5 LATAM
1.5 Data Sources
1.5.1 Secondary
1.5.1.1 Paid Sources
1.5.1.2 Public Sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Citrus Bioflavonoids industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Source Trends.
2.1.3 Product Trends.
2.1.4 Type Trends.
2.1.5 Application Trends.
2.1.6 Regional trends
Chapter 3 Global Citrus Bioflavonoids Industry Insights
3.1 Industry segmentation
3.2 Industry size & forecast, 2018 – 2032
3.2.1 COVID-19 impact on the industry landscape
3.3 Industry ecosystem analysis
3.3.1 Vendor matrix
3.3.2 Distribution channel analysis
3.3.2.1 Distributors
3.3.3 COVID-19 impact on the industry value chain
3.4 Raw material analysis
3.4.1 Orange
3.4.2 Lemon and lime
3.4.3 Grapefruit
3.4.4 Tangerine
3.4.5 Raw material analysis of the COVID-19 impact on supply
3.5 Technology landscape
3.5.1 Hesperidin production process
3.5.2 Eriocitrin production process
3.5.3 Apigenin production process
3.5.4 Diosmin production process
3.5.5 Naringin production process
3.5.6 Narirutin production process
3.6 Cost structure analysis, 2022
3.6.1 Citrus bioflavonoids production cost
3.7 Regulatory landscape
3.7.1 Europe
3.7.2 U.S.
3.7.3 FDA
3.8 Pricing analysis, 2018 – 2032
3.8.1 Citrus Bioflavonoids pricing trends
3.8.1.1 Citrus Bioflavonoids price trends
3.8.2 COVID Impact on pricing trends
3.9 Industry impact forces
3.9.1 Growth drivers
3.9.1.1 North America: Increasing usage of dietary supplements will drive the citrus bioflavonoid market
3.9.1.2 Asia Pacific: Increase in clean-label food consumption promoting citrus bioflavonoid demand
3.9.2 Industry pitfalls & challenges
3.9.2.1 Side effects and restrictions
3.10 Innovation & sustainability
3.11 Growth potential analysis
3.11.1 By application
3.11.2 Emerging business models
3.11.2.1 Acquisitions
3.11.2.2 Collaboration/Joint ventures
3.11.2.3 New product launches
3.11.2.4 Capacity expansion
3.12 Porter’s analysis
3.12.1 Bargaining power of suppliers
3.12.2 Bargaining power of buyers
3.12.3 Threat of new entrants
3.12.4 Threat of substitutes
3.13 PESTEL analysis
3.14 COVID-19 Impact on applications
3.14.1 Dietary supplements
3.14.2 Food & beverages
3.14.3 Animal feed
3.14.4 Personal care & cosmetics
3.15 COVID-19 overview on world economy
3.16 Impact of Russia-Ukraine war on citrus bioflavonoids market
Chapter 4 Competitive Landscape
4.1 Introduction
4.2 Company market share analysis, 2022
4.3 Competive analysis of key market players, 2022
4.4 Competitive positioning matrix
4.5 Strategic outlook matrix
Chapter 5 Citrus Bioflavonoids Market, By Source
5.1 Key Source Trends
5.2 Orange, tangarines, mandarins
5.3 Limes & lemons
5.4 Grapefruit
5.5 Others
Chapter 6 Citrus Bioflavonoids Market, By Product
6.1 Key Grade Trends
6.2 Hesperetin
6.3 Eriocitrin
6.4 Apigenin
6.5 Diosmin
6.6 Naringin
6.7 Narirutin
6.8 Others
Chapter 7 Citrus Bioflavonoids Market, By Type
7.1 Key Type Trends
7.2 Conventional
7.3 Organic
Chapter 8 Citrus Bioflavonoids Market, By Application
8.1 Key Application Trend
8.2 Pharmaceuticals & dietary supplements
8.3 Food & beverages
8.4 Animal feed
8.5 Cosmetics & Personal care
Chapter 9 Citrus Bioflavonoids Market, By Region
9.1 Key regional trends
9.2 North America
9.2.6 U.S.
9.2.7 Canada
9.2.8 Mexico
9.3 Europe
9.3.6 Germany
9.3.7 UK
9.3.8 France
9.3.9 Italy
9.3.10 Spain
9.3.11 Russia
9.3.12 Poland
9.4 Asia Pacific
9.4.6 China
9.4.7 India
9.4.8 Japan
9.4.9 Australia
9.4.10 South Korea
9.4.11 Thailand
9.5 Latin America
9.5.6 Brazil
9.6 MEA
9.6.6 Saudi Arabia
9.6.7 UAE
9.6.8 South Africa
Chapter 10 Company Profiles
10.1 Ingredients by Nature (IBN)
10.2 Freeda Vitamins Inc
10.3 Solgar Inc.
10.4 Organika Health Products Inc. (Organika)
10.5 Natural Factors Inc
10.6 NOW Foods, Inc.
10.7 Country Life LLC
10.8 Cayman Chemical Company Incorporated
10.9 Merck KGaA
10.10 Nans Products
10.11 Shaanxi Kingsci Biotechnology Co., Ltd
10.12 BOC Sciences
10.13 Santa Cruz Biotechnology, Inc
10.15 NutraCap Labs, LLC
10.16 Hunan Yuantong Pharmaceutical Co., Ltd
10.17 Yaan Times Biotech
10.18 Destilaciones Bordas Chinchurreta S.A
10.19 Hunan Sunfull Bio-tech Co., Ltd
10.20 MORRE-TEC Industries, Inc.
